Neo/Adj Tx for HER2- EBC
Key Decision Points in Neoadjuvant and Adjuvant Treatment Selection for Early-Stage HER2-Negative Breast Cancer

Released: August 28, 2023

Joyce O'Shaughnessy
Joyce O'Shaughnessy, MD

Activity

Progress
1
Course Completed